Browse
We’re here to help

Find guidance on Author Services

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 9, Issue 6

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 9, Issue 6 (2000)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 9, Issue 6 (2000)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Volume 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

Novel non-operative treatment and treatment strategies in pancreatic cancer

Simon R Bramhall

Pages: 1179-1195

Published online: 24 Feb 2005

AbstractforNovel non-operative treatment and treatment strategies in pancreatic cancer | References | PDF (221.6 KB)

41 Views
6 CrossRef citations
0Altmetric

Review Article

Targeted therapies for the myeloid leukaemias

Peter Maslak & David Scheinberg

Pages: 1197-1205

Published online: 24 Feb 2005

AbstractforTargeted therapies for the myeloid leukaemias | References | PDF (128.9 KB)

67 Views
12 CrossRef citations
0Altmetric

Review Article

Molecular advances to treat cancer of the brain

Hassan M Fathallah-Shaykh, Li-Juan Zhao, Bruce Mickey & Abdallah I Kafrouni

Pages: 1207-1215

Published online: 24 Feb 2005

AbstractforMolecular advances to treat cancer of the brain | References | PDF (140.4 KB)

49 Views
4 CrossRef citations
0Altmetric

Review Article

Prostate cancer immunotherapy at the dawn of the new millennium

Michael L Salgaller

Pages: 1217-1229

Published online: 24 Feb 2005

AbstractforProstate cancer immunotherapy at the dawn of the new millennium | References | PDF (173.6 KB)

19 Views
6 CrossRef citations
0Altmetric

Review Article

Recombinant antibodies: a novel approach to cancer diagnosis and therapy

Peter J Hudson

Pages: 1231-1242

Published online: 24 Feb 2005

AbstractforRecombinant antibodies: a novel approach to cancer diagnosis and therapy | References | PDF (222.6 KB)

168 Views
17 CrossRef citations
0Altmetric

Review Article

Microbial pathogens and apoptotic anticancer therapy

Vladimir Pasechnik

Pages: 1243-1256

Published online: 24 Feb 2005

AbstractforMicrobial pathogens and apoptotic anticancer therapy | References | PDF (184.8 KB)

28 Views
1 CrossRef citations
0Altmetric

Review Article

Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia

David B Lovejoy & Des R Richardson

Pages: 1257-1270

Published online: 24 Feb 2005

AbstractforComplexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia | References | PDF (204.8 KB)

72 Views
15 CrossRef citations
0Altmetric

Review Article

Small molecule αv integrin antagonists: novel anticancer agents

Janet S Kerr, Andrew M Slee & Shaker A Mousa

Pages: 1271-1279

Published online: 24 Feb 2005

AbstractforSmall molecule αv integrin antagonists: novel anticancer agents | References | PDF (177.7 KB)

144 Views
35 CrossRef citations
0Altmetric

Review Article

αvβ3 Integrin antagonists as inhibitors of bone resorption

George D Hartman & Mark E Duggan

Pages: 1281-1291

Published online: 24 Feb 2005

Abstractforαvβ3 Integrin antagonists as inhibitors of bone resorption | References | PDF (192.2 KB)

98 Views
53 CrossRef citations
0Altmetric

Review Article

The parathyroid hormone, its fragments and analogues - potent bone-builders for treating osteoporosis

James Whitfield, Paul Morley & Gordon Willick

Pages: 1293-1315

Published online: 24 Feb 2005

AbstractforThe parathyroid hormone, its fragments and analogues - potent bone-builders for treating osteoporosis | References | PDF (294.4 KB)

36 Views
20 CrossRef citations
0Altmetric

Review Article

Novel anti-obesity drugs

Joseph Proietto, Barbara C Fam, Deborah A Ainslie & Anne W Thorburn

Pages: 1317-1326

Published online: 24 Feb 2005

AbstractforNovel anti-obesity drugs | References | PDF (164.7 KB)

129 Views
26 CrossRef citations
0Altmetric

Review Article

The role of NPY in metabolic homeostasis: implications for obesity therapy

Heike A Wieland, Bradford S Hamilton, Bernd Krist & Henri N Doods

Pages: 1327-1346

Published online: 24 Feb 2005

AbstractforThe role of NPY in metabolic homeostasis: implications for obesity therapy | References | PDF (351.7 KB)

90 Views
35 CrossRef citations
0Altmetric

Review Article

Insulin sensitiser drugs

Elaine Murphy & John J Nolan

Pages: 1347-1361

Published online: 24 Feb 2005

AbstractforInsulin sensitiser drugs | References | PDF (212.5 KB)

36 Views
7 CrossRef citations
0Altmetric

Review Article

Novel agents in the therapy of endotoxic shock

Lisa M Howe

Pages: 1363-1372

Published online: 24 Feb 2005

AbstractforNovel agents in the therapy of endotoxic shock | References | PDF (161.8 KB)

19 Views
10 CrossRef citations
0Altmetric

Drug Evaluation

Article

An update on satraplatin: the first orally available platinum anticancer drug

Lloyd R Kelland

Pages: 1373-1382

Published online: 24 Feb 2005

AbstractforAn update on satraplatin: the first orally available platinum anticancer drug | References | PDF (160.7 KB)

201 Views
73 CrossRef citations
0Altmetric

Article

TNP-470: an angiogenesis inhibitor in clinical development for cancer

Erwin A Kruger & William D Figg

Pages: 1383-1396

Published online: 24 Feb 2005

AbstractforTNP-470: an angiogenesis inhibitor in clinical development for cancer | References | PDF (208.2 KB)

394 Views
103 CrossRef citations
0Altmetric

Article

Evaluation of memantine for neuroprotection in dementia

Kewal K Jain

Pages: 1397-1406

Published online: 24 Feb 2005

AbstractforEvaluation of memantine for neuroprotection in dementia | References | PDF (141.9 KB)

199 Views
90 CrossRef citations
0Altmetric

Meeting Report

American Association for Cancer Research

Michael L Salgaller

Pages: 1407-1412

Published online: 24 Feb 2005

AbstractforAmerican Association for Cancer Research | PDF (89.4 KB)

12 Views
3 CrossRef citations
0Altmetric

Meeting Report

American Association for Cancer Research

Michael L Salgaller

Pages: 1413-1417

Published online: 24 Feb 2005

AbstractforAmerican Association for Cancer Research | PDF (80.9 KB)

15 Views
1 CrossRef citations
0Altmetric

Meeting Report

American Association for Cancer Research

Gopi Shankar

Pages: 1419-1424

Published online: 24 Feb 2005

AbstractforAmerican Association for Cancer Research | References | PDF (101.9 KB)

14 Views
0 CrossRef citations
0Altmetric

Meeting Report

The Future of Plasma Derivatives

Clive H Dash

Pages: 1425-1431

Published online: 24 Feb 2005

AbstractforThe Future of Plasma Derivatives | PDF (101.7 KB)

23 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Early psoriatic arthritis: clinical and therapeutic challenges.

Francesco Caso et al.

Review Article | Published online: 23 Jul 2024

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents

Elisabeth Amadeo et al.

Review Article | Published online: 22 Jul 2024

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.9, Iss.6, 2000)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?